NCT01371981 2025-11-26Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting1,645 enrolled 32 charts
NCT02521493 2025-08-01Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeChildren's Oncology GroupPhase 3 Active not recruiting280 enrolled 13 charts